Effect of Cyclophosphamide on Expression of MMP-9 and TGF-β1 in Renal Tissue of Rats with Diabetes Mellitus

Cell Biochemistry and Biophysics

Volumn 72, Issue 2, 2015, Pages 399-403

  Zhang, Yan ^a   Wu, Ge ^a   Hu, Xiaozhou ^a   Zhang, Jin ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cyclophosphamide; Diabetic nephropathy; Matrix metalloproteinase; Transforming growth factor 1

Indexed keywords

RATTUS;

CYCLOPHOSPHAMIDE; GELATINASE B; GLUCOSE BLOOD LEVEL; MMP9 PROTEIN, RAT; NITROGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; BLOOD; DIABETIC NEPHROPATHY; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; KIDNEY; METABOLISM; RAT; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; BLOOD GLUCOSE; CYCLOPHOSPHAMIDE; DIABETIC NEPHROPATHIES; KIDNEY; MATRIX METALLOPROTEINASE 9; NITROGEN; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84930866086     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-0474-7     Document Type: Article

References (20)

1. Wang, J., Gao, Y., Ma, M., et al. (2013). Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice. Cell Biochemistry and Biophysics,67(2), 537–546.
2. Somani, R., Singhai, A. K., Shivgunde, P., et al. (2012). Asparagus racemosus Willd (Liliaceae) ameliorates early diabetic nephropathy in STZ induced diabetic rats. Indian Journal of Experimental Biology,50(7), 469–475.
3. Michael, S. T., Ganesh, R. N., Viswanathan, P., et al. (2012). Effect of long acting insulin supplementation on diabetic nephropathy in Wistar rats. Indian Journal of Experimental Biology,50(12), 867–874.
4. Hirayama, A., Nakashima, E., Sugimoto, M., et al. (2012). Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Analytical and Bioanalytical Chemistry,404(10), 3101–3109.
5. Plum, L. A., & Zella, J. B. (2012). Vitamin D compounds and diabetic nephropathy. Archives of Biochemistry and Biophysics,523(1), 87–94.
6. Donadio, J. V, Jr, Torres, V. E., Velosa, J. A., et al. (1988). Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney International,33(3), 708–715.
7. Zhu, C., Liang, Q.-L., Hu, P., et al. (2011). Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy. Talanta,85(4), 1711–1720.
8. Datta, S. K., Kumar, V., Ahmed, R. S., et al. (2010). Effect of GSTM1 and GSTT1 double deletions in the development of oxidative stress in diabetic nephropathy patients. Indian Journal of Biochemistry & Biophysics,47(2), 100–103.
9. Jiang, Z. T., Liang, Q. L., Luo, G. A., et al. (2009). HPLC-electrospray tandem mass spectrometry for simultaneous quantitation of eight plasma aminothiols: Application to studies of diabetic nephropathy. Talanta,77(4), 1279–1284.
10. Zhang, Jie, Yan, Lijuan, Chen, Wengui, et al. (2009). Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system. Analytica Chimica Acta,650(1), 16–22.
11. Xia, J. F., Liang, Q. L., Liang, X. P., et al. (2009). Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences,877(20/21), 1930–1936.
12. Bock, F., Shahzad, K., Wang, H., et al. (2013). Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66 ~ (Shc). Proceedings of the National Academy of Sciences of the USA,110(2), 648–653.
13. Mizuno, S., & Nakamura, T. (2004). Suppressions of chronic glomerular injuries and TGF-β1 production by HGF in attenuation of murine diabetic nephropathy. American Journal of Physiology-Renal Physiology,286(1), F134–F143.
14. Russo, L. M., del Re, E., Brown, D., et al. (2007). Evidence for a role of transforming growth factor (TGF)-β1 in the induction of postglomerular albuminuria in diabetic nephropathy amelioration by soluble TGF-β type II receptor. Diabetes,56(2), 380–388.
15. Schaan, B. D. A., Lacchini, S., Bertoluci, M. C., et al. (2001). Increased renal GLUT1 abundance and urinary TGF-β1 in streptozotocin-induced diabetic rats: Implications for the development of nephropathy complicating diabetes. Hormone and Metabolic Research,33(11), 664–669.
16. Lin, M.-H., Chen, H.-Y., Liao, T.-H., et al. (2011). Determination of time-dependent accumulation of d-lactate in the streptozotocin-induced diabetic rat kidney by column-switching HPLC with fluorescence detection. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences,879(29), 3214–3219.
17. Wolf, G., & Ziyadeh, F. N. (2007). Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiology,106(2), 26–31.
18. Mariee, A. D., Abd-Allah, G. M., El-Yamany, M. F., et al. (2009). Renal oxidative stress and nitric oxide production in streptozotocin-induced diabetic nephropathy in rats: The possible modulatory effects of garlic (Allium sativum L.). Biotechnology and Applied Biochemistry,52(3), 227–232.
19. Kiran, G., Nandini, C. D., Ramesh, H. P., et al. (2012). Progression of early phase diabetic nephropathy in streptozotocin-induced diabetic rats: Evaluation of various kidney-related parameters. Indian Journal of Experimental Biology,50(2), 133–140.
20. Hamano, Y., Zeisberg, M., Sugimoto, H., et al. (2003). Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin. Cancer Cell,3(6), 589–601.